Showing results (41-50 of 141) with videos related to

Sort By:
Pageof 15
Sportverletzung Sportschaden : Organ Der Gesellschaft Fur Orthopadisch-Traumatologische Sportmedizin|February 25, 2015
[Reliability of Selected Parameters of Cycling Ergospirometry from the PowerCube-Ergo Respiratory Gas Analyser]M W Hoppe, B Sperlich, C Baumgart, et al.
International Journal of Sports Medicine|March 12, 2015
Match Running Performance and Success Across a Season in German Bundesliga Soccer TeamsM W Hoppe, M Slomka, C Baumgart, et al.
Inflammatory Bowel Diseases|February 26, 2011
Frequency, phenotype, outcome, and therapeutic impact of skin reactions following initiation of adalimumab therapy: experience from a consecutive cohort of inflammatory bowel disease patientsDaniel C Baumgart, Ulrike Grittner, Andrea Steingräber, et al.
Inflammatory Bowel Diseases|January 31, 2007
Lipoxins and resolvins in inflammatory bowel diseaseKarsten H Weylandt, Jing X Kang, Bertram Wiedenmann, et al.
Alimentary Pharmacology & Therapeutics|April 3, 2016
Vedolizumab induction therapy for inflammatory bowel disease in clinical practice--a nationwide consecutive German cohort studyD C Baumgart, B Bokemeyer, A Drabik, et al.
Scientific Reports|February 18, 2022
Artificial intelligence enabled automated diagnosis and grading of ulcerative colitis endoscopy imagesReed T Sutton, Osmar R Zai Ane, Randolph Goebel, et al.
Scandinavian Journal of Gastroenterology|September 17, 2005
Mesalamine promotes intestinal epithelial wound healing in vitro through a TGF-beta-independent mechanismDaniel C Baumgart, Karin Vierziger, Andreas Sturm, et al.
Zeitschrift Fur Gastroenterologie|December 7, 2017
Immunosuppression following liver transplantation and the course of inflammatory bowel disease - a case control studyMartina T Mogl, Daniel C Baumgart, Andreas Fischer, et al.
Lancet (London, England)|August 24, 2012
Ulcerative colitisIngrid Ordás, Lars Eckmann, Mark Talamini, et al.
The American Journal of Gastroenterology|April 1, 2006
Tacrolimus is safe and effective in patients with severe steroid-refractory or steroid-dependent inflammatory bowel disease--a long-term follow-upDaniel C Baumgart, Jan P Pintoffl, Andreas Sturm, et al.
Pageof 15